University of Florida, 2018. The speed of development and effectiveness of vaccines has been matched by public resistance to receiving the vaccine and misinformation [3], mostly over-emphasizing the adverse effects of the vaccine and downplaying the risks of untreated COVID-19, a calculus that also changes with each variant [4]. The Sputnik V vaccine also uses Ad26. official website and that any information you provide is encrypted 2021;148(3):e2021052478. No children who received the combination therapy died or were hospitalized during treatment. Luyten J, Bruyneel L, van Hoek A J. Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument. Take a walk around campus to find a little-known green space closest to you and take a moment for mindfulness using this Google Map we created just for you. Fever or chills. The baseline rates for myocarditis in those age groups are 1.34 [95% CI, 1.051.72] and 0.42 [95% CI, 0.270.66] cases per million persons, respectively. But in each instance, these have appeared soon after widespread use of the vaccine began. PMC https://doi.org/10.1016/S0140-6736(22)00055-1. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use. Oral side effects of COVID-19 vaccine. Here we provide a narrative review of the biologic therapeutics used or proposed to treat COVID-19 during the last 3 years. But the rare side effects identified with COVID vaccines have to be weighed against the known, higher risks from contracting COVID, Goepfert says. Accessed 12 Dec2022. There were no life-threatening reactions. Lancet Infect Dis. An open label phase I/IIa trial evaluating GLS-5300 against SARS-CoV-2 reported no serious adverse events up to 4weeks after injection but the abstract did not specify the number of people enrolled and no full-text was available from the publisher web site, WHO web site or PubMed, only a meeting abstract [43]. This study included patients 18years or older whose symptoms began within the last 5days with at least 1 risk factor for disease progression (2). While the majority of those who have been vaccinated have had no adverse reactions after getting their vaccine, some have experienced side-effects which include body aches, headaches and fever . Association between COVID-19 and myocarditis using hospital-based administrative data - United States, March 2020-January 2021. Accessed 22 Mar 2022. 2021. https://www.fda.gov/media/150320/download. medRxiv.2021.05.07.21256652. Hepatitis B vaccination and associated oral manifestations: A non-systematic review of literature and case reports. In the meantime, to ensure continued support, we are displaying the site without styles As of June 12, 2021, more than 2.33 billion COVID vaccine doses have been administered worldwide, according to the New York Times vaccinations tracker. JAMA. N Engl J Med. Most people will experience very mild symptoms or no side effects at all. Antibody toxicity can arise from an expected effect on the target, an immunologic response to the antibody, or from off-target binding. N Engl J Med. It is administered to patients who have contracted the disease and are at high risk for deterioration without intervention. Pfizer-BioNTech COVID-19 vaccine (also known as COMIRNATY) overview and safety. "The side effects that we see occur early on and that's it," Goepfert said. mRNA vaccines directly inject mRNA into the host cytoplasm, bypassing the introduction of DNA to the nucleus and the need for transcription. The FDA issued an EUA for a one-time infusion of 500mg sotrovimab over 1h on May 26, 2021, for non-hospitalized COVID-19 patients 12years or older, heavier than 40kg, and with at least one risk factor for progression of disease [16]. Michael Chary. Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab. The LNP-mRNA complex is neutral and is taken up by endocytosis into the cell. Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech 2021;301(2):E40911. Our search strategy may be biased towards mild and moderate effects, which are assiduously reported by clinical trials. FDA grants Dupixent (dupilumab) Breakthrough Therapy designation for eosinophilic esophagitis * Designation based on positive results from Part A of pivotal Phase 3 trial * Dupixent is the first and only biologic to show positive and clinically-meaningful Phase 3 results in patients 12 years and older with eosinophilic esophagitis (EoE) * There are currently no FDA-approved treatments for . Available from. This increase is less than the risk of developing myocarditis from COVID-19 (relative risk: 2 [95% CI, 1.442.65, vaccinated] vs 15 [95% CI, 11.0919.8, unvaccinated]) [86, 87]. Side effects of the coronavirus (COVID-19) vaccination Very common side effects in the first day or two include: having a painful, heavy feeling and tenderness in the arm where you had your injection feeling tired headache, aches and chills diarrhoea, nausea and vomiting mild flu-like symptoms Think eating healthier is too expensive to try? Granados Villalpando JM, Romero Tapia SJ, Baeza Flores GDC, Ble Castillo JL, Juarez Rojop IE, Lopez Junco FI, Olvera Hernndez V, Quiroz Gomez S, Ruiz Quiones JA, Guzmn Priego CG. Nature. SARS-CoV-2 Neutralizing antibody LY-CoV555 in outpatients with Covid-19. Any risk is frightening, especially for a parent. Other viral infections are associated . One year into the pandemic the United States Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for Pfizers vaccine, marking a shift in efforts from repurposing medications to widespread vaccination. You can email the site owner to let them know you were blocked. The authors attributed most of these adverse events to disease progression. Most people also need a booster dose to help improve the protection from the first 2 doses of the vaccine. Tocilizumab in hospitalized patients with severe Covid-19 pneumonia. Fischer S, Gerriets T, Wessels C, Walberer M, et al. Chen P, Nirula A, Heller B, Gottlieb RL, et al. 2020 Dec 1;16(12):2891-2904. doi: 10.1080/21645515.2020.1788310. An analysis of 50,000 hospitalized patients with COVID who received convalescent plasma through the FDAs Early Access Program reported transfusion reactions (n=78), thromboembolic or thrombotic events (n=113, 75 judged unrelated), and cardiac events (n=677; 597 judged unrelated), mainly myocarditis and acute coronary syndrome [10]. Google Scholar. Do COVID-19 vaccines really have worse side effects than other vaccines While the Pfizer report above focused on events that produced severe reactions greater than 2 percent of the time, the CDC reports that other side effects include . https://doi.org/10.1128/JVI.02407-10. Yes, Goepfert said. No serious adverse events or deaths were reported in any group. The Oxford-AstraZeneca and Johnson & Johnson vaccines are both DNA vaccines that use adenovirus as a vector. Fatigue. They were initially identified from convalescent plasma obtained from COVID-19 survivors. In December 2021, the FDA issued an EUA for sotrovimab [12], bamlanivimab/etesevimab [13], and casirivimab/imdevimab [14] to treat non-hospitalized immunosuppressed patients who are at high risk for progression of COVID-19 symptoms. FDA issues emergency use authorization for third COVID-19 vaccine. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: case series of four critically ill patients treated with leronlimab. ; C4591001 Clinical Trial Group . https://doi.org/10.1056/NEJMc2105869, Niesen MJM, Pawlowski C, O'Horo JC, Challener DW, et al. Oral side effects of COVID-19 vaccine - PubMed Headlines wont help you lose weight. 2021;39(22):3081101. The most common adverse events attributed to tocilizumab are an increased incidence of opportunistic infections, reflecting immunosuppression, and clinically insignificant dyslipidemia [28]. https://doi.org/10.1007/s40264-021-01104-9. After DNA vaccines, those aged 3050 are very slightly more likely to have thrombotic disease. government site. It works by developing immunity to the receptor binding domain of the S protein [108]. We provide expected values that we calculated for comparison, although the expected values are cases per person and reported values cases per vaccine dose. 2021;73(11):e40829. And 26% of respondents in a survey of parents with children ages 12-15 by the Kaiser Family Foundation in April 2021 said they wanted to wait a while to see how the vaccine is working before deciding to get their child vaccinated. The most reported symptoms from clinical trials were pain at the injection site (48.6%), headache (38.9%), fatigue (38.2%), myalgia (33.1%), and nausea (14.2%) [50]. Breedveld FC. There have been no reports of thromboembolic events from Russian health authorities or from those other nations using Sputnik V [116]. JAMA. 2021;21(6):38293. Vaccine 2019; 37: 2494-2501. HHS Vulnerability Disclosure, Help The most common side effects following COVID-19 vaccines are fatigue, a fever, headaches, body aches, chills, nausea, diarrhea, and pain at the site of injection, according to the World. 2021 May 7;18(9):4965. doi: 10.3390/ijerph18094965. 2021;385(23):e81. Michael A. Chary is supported by the Loan Repayment Program (National Institute for Drug Abuse, National Institutes of Health). Chary MA, Barbuto AF, Izadmehr S, Hayes BD, Burns MM. Drinking lots of fluids is wise if you're feverish, and wearing lightweight clothing can also keep you comfortable. The most frequent serious adverse events more frequent in the vaccine group were myocardial infarction (5 vs 3 cases), cholecystitis (3 vs 0 cases), and nephrolithiasis (3 vs 0 cases). Facilitators and barriers to COVID-19 vaccine uptake among women in two regions of Ghana: A qualitative study. These are very transient, and occur a day or two days after the vaccine. Turn your October into WALKtober with Employee Wellness, What are the long-term side effects of COVID vaccines? Abstract 955 in 2020 ASGCT Annual Meeting Abstracts. 2021;325(15):15351544. Angioedema occurred in 0.2% of those in the vaccine group in contrast to 0.1% in the placebo group, urticaria in 8 vs 3 individuals and tinnitus in 6 vs 0, respectively. Possible side effects of Paxlovid include impaired sense of taste, diarrhea, high blood pressure and muscle aches. U.S. Food and Drug Administration. Don't miss: The best credit cards for building credit. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Mounting evidence suggests Sputnik COVID vaccine is safe and effective. nausea. 2021 Feb 9;325(6):532-533. doi: 10.1001/jama.2020.26553. The most reported symptoms after the first and second doses were pain at the injection site (83.7% and 88.7%, respectively), fatigue (37.2% and 65.2%), headache (32.7% and 58.5%), muscle pain (22.7% and 57.6%), and arthralgia (16.6% and 42.6%) [65]. A meta-analysis of 32 studies (29 cohort studies and 3 clinical trials) found no difference in mortality or frequency of adverse events [26]. That is the most troubling unknown for me., Even as cases, hospitalizations and deaths have declined significantly in Alabama since January, there are still nearly 250 new COVID cases diagnosed and nearly 10 deaths reported statewide per day as of mid-June, Many people worry that these vaccines were rushed into use and still do not have full FDA approval they are currently being distributed under Emergency Use Authorizations, Goepfert said. 2021;384(20):19641965. COVID-19: Vaccine side effects and reactions - Ministry of Health NZ Rosas IO, Bru N, Waters M, Go RC, et al. The mRNA could have off target effects or unanticipated immunogenicity. It is a two-dose COVID-19 vaccine designed to generate antibodies against the S protein. Of 151 healthy volunteers who received the SCB-2019 vaccine almost half reported local site reactions, more frequent with the AS03 adjuvant (4469%) than the CpG/Alum adjuvant (644%) or no adjuvant (313%). 2020. Internet Explorer). COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Vaccines, Monoclonal Antibodies, and Immunotherapeutics). FDA takes key action in fight against COVID-19 by issuing emergency use authorization for first COVID-19 vaccine. Marshall M, Ferguson ID, Lewis P, Jaggi P, et al. Thus, once inside the cell, the LNP and mRNA dissociate, leaving mRNA transcript in the APC cytoplasm that is indistinguishable from the APCs own mRNA. mRNA degrades incredibly rapidly. JAMA. Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial. Anyone you share the following link with will be able to read this content: Sorry, a shareable link is not currently available for this article. PubMed J Med Toxicol. Nat Rev Mater. 2020;106(15):113241. The most frequent were diarrhea (2%) and rash (1%). Zhang Y, Zeng G, Pan H, Li C, et al. Provided by the Springer Nature SharedIt content-sharing initiative, British Dental Journal (Br Dent J) A randomized unblinded clinical trial was reported underway in 2020 in the People's Republic of China [8]. https://doi.org/10.1371/journal.pmed.1003872. 2021;46(2):2707. Covid vaccine: Vaxart shares plunge on weak antibody response to oral Infusion reactions were most commonly pyrexia, chills, dizziness, and dyspnea. Almost all of these cases occurred in the eight weeks after a person received the vaccine. Body pains, mouth ulcers experienced by some healthcare workers after If it happens, healthcare providers can effectively and immediately treat the reaction. 2021;44(11):120914. https://doi.org/10.15585/mmwr.mm7018e2. Another study compared the efficacy of sotrovimab in 546 hospitalized patients with SARS-CoV-2 to 0.9% saline and used the composite endpoint of length-of-stay and recurrent admissions and reported infusion-related adverse events in 18 patients (10%) who received sotrovimab and 14 patients (13%) who received saline. Oral side effects of COVID-19 vaccine. Starekova J, Bluemke DA, Bradham WS, Grist TM, et al. Vaccines (Basel). The type and location of the rashes were not detailed. https://doi.org/10.15585/mmwr.mm7035e5. Annu Rev Immunol. Kishimoto T. Interleukin-6: from basic science to medicine40 years in immunology. Su JR. The proposed mechanism was that APN01 would act as a decoy for the virus, much as andexanet alfa acts as a decoy for factor Xa inhibitors. https://doi.org/10.1007/s13181-020-00777-5. People who had severe illness with COVID-19 might experience organ damage affecting the heart, kidneys, skin and brain. Nausea was the most frequent adverse event, noted in 4 (3.6%) patients who received the combination and 6 (3.8%) who received saline. Its genetic sequence resembles SARS-CoV-1, a beta-coronavirus that caused the SARS (Severe Acute Respiratory Syndrome) epidemic in 2003. The most common adverse events reported 7days after the first or booster vaccine were fever (62 patients, 48%), fatigue (40 patients, 31%), and headache (46 patients, 35%) [107]. Serious adverse events occurred in 103 of 295 patients (34.9%) in the tocilizumab group and in 55 of 143 patients (38.5%) in the placebo group. Fact Sheet for Health Care Providers Emergency Use Authorization (EUA) of REGEN-COV (casirivimab and imdevimab).2021. https://www.fda.gov/media/145611/download. 2022 Jan;22(1):64-72. doi: 10.1016/S1473-3099(21)00451-5. Your IP: A chart review aided by natural language processing of 47, 999 persons who received three doses of mRNAs vaccines (57.3% women, median [IQR] age 67.4 [52.576.5]) found no increased risk of pericarditis, myocarditis, anaphylaxis, or cerebral venous sinus thrombosis after the third dose; however, about 10% more individuals reported fatigue, lymphadenopathy, headache, arthralgias, and myalgias after the third dose than the second [98]. Lamprinou M, Sachinidis A, Stamoula E, Vavilis T, Papazisis G. Immunol Res. The combination therapy uses either 0.9% saline or 5% dextrose in water as its diluent [35]. and transmitted securely. An example of of an expected but undesired effect is immunosuppression from infliximab, which targets TNF-alpha, leading to more frequent infections. editors. "This is particularly true of the mRNA vaccines. Bravo L, Smolenov I, Han HH, Li P, et al. Nainu F, Abidin RS, Bahar MA, Frediansyah A, Emran TB, Rabaan AA, Dhama K, Harapan H. Hum Vaccin Immunother. COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Vaccines, Monoclonal Antibodies, and Immunotherapeutics), https://doi.org/10.1007/s13181-023-00931-9, Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: a systematic review and network meta-analysis, COVID-19: potential therapeutics for pediatric patients, A Narrative Review of the Clinical Practicalities of Bamlanivimab and Etesevimab Antibody Therapies for SARS-CoV-2, COVID-19 vaccines adverse events: potential molecular mechanisms, Managing rheumatic diseases during COVID-19, Repositioned Drugs for COVID-19the Impact on Multiple Organs, https://doi.org/10.1136/heartjnl-2020-317056, https://doi.org/10.1007/s10900-020-00958-x, https://doi.org/10.26355/eurrev_202102_24877, https://doi.org/10.1007/s13181-020-00777-5, https://doi.org/10.1038/s41401-020-0485-4, https://www.med.ubc.ca/news/pilot-clinical-trial-in-china-to-test-ubc-researchers-findings-as-a-targeted-therapy-for-covid-19/, https://doi.org/10.1371/journal.pmed.1003872, https://doi.org/10.1016/s0140-6736(00)01034-5, https://www.fda.gov/media/149534/download, https://www.fda.gov/media/145802/download, https://www.fda.gov/media/145611/download, https://doi.org/10.1038/s41577-021-00542-x, https://doi.org/10.1016/j.jtauto.2021.100083, https://doi.org/10.1016/S0140-6736(21)00676-0, https://doi.org/10.1016/j.jhep.2016.02.004, https://doi.org/10.1146/annurev.immunol.23.021704.115806, https://doi.org/10.1038/s41375-021-01264-8, https://www.fda.gov/media/150320/download, https://doi.org/10.1016/S1473-3099(21)00751-9, https://doi.org/10.1080/21645515.2021.2002083, https://doi.org/10.1016/S0140-6736(21)00241-5, https://doi.org/10.1016/S0140-6736(22)00055-1, https://doi.org/10.1016/j.eclinm.2020.100689, https://doi.org/10.1101/2021.05.07.21256652, https://doi.org/10.1038/s41541-020-00243-x, https://doi.org/10.1016/j.vaccine.2020.09.018, https://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-third-covid-19-vaccine, https://www.cdc.gov/vaccines/covid-19/info-by-product/janssen/reactogenicity.html, https://doi.org/10.1007/s00441-014-1850-8, https://doi.org/10.1182/blood-2006-08-040691, https://doi.org/10.1016/j.jconrel.2021.03.043, https://doi.org/10.1038/s41578-021-00281-4, https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19, https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use, https://www.fda.gov/news-events/press-announcements/fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use-children-5-through-11-years-age, https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/reactogenicity.html, https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/reactogenicity.html, https://doi.org/10.1016/j.vaccine.2021.09.004, https://doi.org/10.1148/radiol.2021211430, https://doi.org/10.1148/radiol.2021211766, https://www.cdc.gov/vaccines/covid-19/clinical-considerations/myocarditis.html, https://doi.org/10.1161/CIRCULATIONAHA.121.055891, https://doi.org/10.1001/jamacardio.2021.2833, https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2022-01-05/02-covid-su-508.pdf, https://doi.org/10.1001/jamacardio.2021.3471, https://doi.org/10.1161/CIRCULATIONAHA.121.056135, https://doi.org/10.1007/s40264-021-01104-9, https://doi.org/10.1001/jamanetworkopen.2021.22255, https://doi.org/10.1016/j.ijcard.2018.09.054, https://doi.org/10.1161/CIRCULATIONAHA.122.059970, https://doi.org/10.1371/journal.pone.0118283, https://doi.org/10.1016/j.jacc.2003.11.053, https://doi.org/10.1016/j.bja.2018.04.014, https://doi.org/10.1001/jamanetworkopen.2022.7038, https://doi.org/10.1038/d41586-021-02796-w, https://doi.org/10.1016/S1473-3099(20)30843-4, https://doi.org/10.1016/S0140-6736(21)01429-X, https://www.precisionvaccinations.com/vaccines/sinopharm-covid-19-vaccine-bbibp-corv, https://doi.org/10.1016/j.cmi.2021.11.011, https://doi.org/10.1001/jamanetworkopen.2021.30800, https://doi.org/10.1016/S1473-3099(21)00396-0, https://doi.org/10.1126/sciimmunol.aaf7643, https://doi.org/10.1016/j.lanepe.2021.100241, https://doi.org/10.1038/s41598-021-00963-7, https://doi.org/10.1016/j.intimp.2021.108351, https://doi.org/10.1038/d41586-021-01813-2. Join University Recreations spring mindfulness series Jan. 25-April 14 to begin practicing mindfulness strategies to reduce stress and improve mental health. J Exp Med. Most cases (67%) occurred in males. Tang CH, Hsu CJ, Fong YC. https://doi.org/10.1182/blood-2006-08-040691. All had chest pain, troponin elevation, and abnormal cardiac MRI (most commonly late gadolinium enhancement). https://doi.org/10.1126/sciimmunol.aaf7643, Stephenson KE, Le Gars M, Sadoff J, de Groot AM, et al. That is about one in a million, or possibly higher rates in some populations; but again, all of these occur no more than a month after the vaccination.. https://doi.org/10.1056/NEJMoa2202261. Sore arms, muscle pain, fatigue, headaches and fevers are common . Anaphylaxis, a severe type of allergic reaction, can occur after any kind of vaccination. PLoS Med. INO-4800 is a DNA vaccine that encodes the SARS-CoV-2 S protein. 2020;288:198114. Study reveals extent of Covid vaccine side-effects - BBC News You wouldnt expect any of these vaccines to have any long-term side effects. That is not to say that there have never been safety issues with vaccines. N Engl J Med. 2022 Dec;114(6):601-612. doi: 10.1016/j.jnma.2022.08.003. "The long-term side effects of COVID infection are a major concern. COVID-19 Might Cause Mouth Lesions, New Study Suggests - CreakyJoints In addition, five patients (1%) who received sotrovimab reported infusion-related reactions compared with 6 (1%) who received saline. quantifying the efficacy of 5 COVID vaccines reported that SinoPharm was 68% effective, but many participants mixed and matched vaccines and adverse events were not recorded [105]. But the rare side effects identified with COVID vaccines have to be weighed against the known, higher risks from contracting COVID, Goepfert says. https://doi.org/10.4161/mabs.2.3.11782. https://doi.org/10.4110/in.2015.15.2.51. The FDA granted bamlanivimab an EUA based on interim results from the Blaze-1 clinical trial which reported that 2800mg of bamlanivimab decreased viral load by a factor of 3.4 by day 11 of symptom onset compared to saline [33]. Systemic adverse events were more frequent in those adults younger than 30 (38%) than in older adults (17%) [40]. Covid vaccines come with some side effects, which is a sign that your immune system is getting to work and mounting protection to the virus. eCollection 2022. 2023 Springer Nature Switzerland AG. We have all seen billboards and TV infomercials from law firms seeking people harmed by diet drugs or acid-reflux medicines for class-action lawsuits. Safety monitoring of the Janssen (Johnson & Johnson) COVID-19 vaccine - United States, March-April 2021. MAbs. PubMed Accessibility 2016;1(5):eaaf7643. Vaccines stimulate the production of antibodies that interact with a specific part of the virus (the epitope). We could find no toxicity data to present. 2021;325(24):24482456. PMC Of those patients, 98% were male. Results: Six patients who received the vaccines developed appendicitis in the following 28days, compared with 5 who received the placebo. FDA takes additional action in fight against COVID-19 by issuing emergency use authorization for second COVID-19 vaccine. Many Americans say they want to make sure the shot is safe before getting vaccinated. https://doi.org/10.1016/j.cmi.2021.11.011. One case of urticaria 48h after a patient received the 6g injection was reported and the patient recovered after being treated with chlorpheniramine and dexamethasone with no recrudescence after the second dose of vaccine. https://doi.org/10.1084/jem.98.6.641. In our previous publication we discussed the recombinant protein APN01, humanized antibody leronlimab, nucleotide analogs remdesivir and favipiravir, protease inhibitors lopinavir/ritonavir, DNA vaccines (S-trimer, INO-4800, GLS-5300), the Moderna mRNA vaccine, and convalescent plasma [5]. They found that six of 21 COVID-19 patients who had external skin rashes also had oral lesions. Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019. Pediatrics. The https:// ensures that you are connecting to the The CDC's guidance on common vaccine side effects lists many of the same ones Chambers mentioned: fever, chills, headaches, nausea, and muscle pain or exhaustion. Here we provide a narrative review of the biologic therapeutics used or proposed to treat COVID-19 during the last 3years. https://doi.org/10.1001/jamanetworkopen.2021.22255, CDC COVID-19 Response Team; Food and Drug Administration. Both antibodies bind to the RBD, but they target different regions of the RBD, like the combination of bamlanivimab and etesevimab. To date, no clinical trials have been performed. In the larger Phase 2/3 SPECTRA trial, mild-to-moderate injection site pain was reported more by those who received the vaccine (n=6215) than the placebo (n=6104) after the first (35.7%; 287 of 803 vs 10.3%; 81 of 786) or second dose (26.9%; 189 of 702 vs 7.4%; 52 of 699). Muir KL, Kallam A, Koepsell SA, Gundabolu K. Thrombotic thrombocytopenia after Ad26.COV2.S vaccination. Google Scholar. Afrifa-Anane GF, Larbi RT, Addo B, Agyekum MW, Kyei-Arthur F, Appiah M, Agyemang CO, Sakada IG. As of January 2022, sotrovimab is the only available monoclonal antibody believed effective against the omicron variant, illustrating the dependence of the efficacy of monoclonal antibodies on viral structure. Embolic and thrombotic events occurred at a frequency of 0.06% in the vaccine group and 0.05% in the placebo group. Vok Z, Kiss Z, Surjn G, Surjn O, et al. Iftikhar H, Noor SMU, Masood M, Bashir K. Cureus. Lancet Infect Dis. https://doi.org/10.1038/d41586-021-01813-2. University of Florida, 2018. myStrength to help employees improve mental, emotional well-being, 2023 The University of Alabama at Birmingham. Serious adverse events were reported by 199 patients (1.4%) in the ZF2001 group and 264 patients (1.8%) in the placebo group.